37 related articles for article (PubMed ID: 3116197)
21. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
Freneaux E; Fromenty B; Berson A; Labbe G; Degott C; Letteron P; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1990 Nov; 255(2):529-35. PubMed ID: 2123005
[TBL] [Abstract][Full Text] [Related]
22. Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions.
Deschamps D; DeBeco V; Fisch C; Fromenty B; Guillouzo A; Pessayre D
Hepatology; 1994 Apr; 19(4):948-61. PubMed ID: 8138270
[TBL] [Abstract][Full Text] [Related]
23. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
Le Dinh T; Freneaux E; Labbe G; Letteron P; Degott C; Geneve J; Berson A; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1988 Nov; 247(2):745-50. PubMed ID: 3183967
[TBL] [Abstract][Full Text] [Related]
24. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
Fromenty B; Fisch C; Labbe G; Degott C; Deschamps D; Berson A; Letteron P; Pessayre D
J Pharmacol Exp Ther; 1990 Dec; 255(3):1371-6. PubMed ID: 2124623
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of valproate to hepatotoxic intermediates.
Baillie TA
Pharm Weekbl Sci; 1992 Jun; 14(3A):122-5. PubMed ID: 1502011
[TBL] [Abstract][Full Text] [Related]
26. Acute fatty liver of pregnancy: an update on mechanisms.
Natarajan SK; Thangaraj KR; Goel A; Eapen CE; Balasubramanian KA; Ramachandran A
Obstet Med; 2011 Sep; 4(3):99-103. PubMed ID: 27579101
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
Geneve J; Hayat-Bonan B; Labbe G; Degott C; Letteron P; Freneaux E; Dinh TL; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1987 Sep; 242(3):1133-7. PubMed ID: 3116197
[TBL] [Abstract][Full Text] [Related]
28. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines.
Fromenty B; Pessayre D
J Hepatol; 1997; 26 Suppl 2():43-53. PubMed ID: 9204409
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity.
Fromenty B; Pessayre D
Pharmacol Ther; 1995; 67(1):101-54. PubMed ID: 7494860
[TBL] [Abstract][Full Text] [Related]
30. Fatal acute liver failure associated with pirprofen. Report of a case and a review of the literature.
Depla AC; Vermeersch PH; van Gorp LH; Nadorp JH
Neth J Med; 1990 Aug; 37(1-2):32-6. PubMed ID: 2215831
[TBL] [Abstract][Full Text] [Related]
31. Microvesicular steatosis of the liver.
Hautekeete ML; Degott C; Benhamou JP
Acta Clin Belg; 1990; 45(5):311-26. PubMed ID: 2177300
[TBL] [Abstract][Full Text] [Related]
32. Hepatotoxicity due to mitochondrial dysfunction.
Pessayre D; Mansouri A; Haouzi D; Fromenty B
Cell Biol Toxicol; 1999; 15(6):367-73. PubMed ID: 10811531
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]